SACRAMENTO, Calif., Sept. 06, 2017 -- IDdriven, Inc., (OTC:IDDR), an innovative provider of premises and cloud-based Identity and Access Management ("IAM") solutions is pleased to announce today that Rhode Island based health system Lifespan, selected IDdriven for its identity management and access solution.
Lifespan is the first health system of Rhode Island and operates multiple hospitals, institutes and services, with over 19,000 employees and contractors.
Major part of the decision was a reliable certification and attestation, but also the user-friendliness of the IDdriven solution played a role.
Headquartered in Providence, Rhode Island, Lifespan is one of the most highly regarded hospital care companies in the area. Lifespan is planning to have IDdriven operational at the beginning of the fourth quarter.
Arend Verweij, CEO of IDdriven, Inc. stated, “We look forward to a long relation with Lifespan. We have recently seen an increasing demand for Identity and access management solutions in the medical market. Our IDdriven solution fits in there very well.”
About IDdriven
With its next-generation IDaaS program of the same name, IDdriven, Inc. is at the forefront of the new breed of Identity Management and Access Governance solutions. Taking the complexity and upfront costs out of implementation, IDdriven automates access security for vulnerable company assets by seamlessly integrating with the solutions from Microsoft, and other cloud providers like Amazon. Founded in 2013, IDdriven is headquartered in Sacramento, California. To learn more, visit: www.IDdriven.com.
Forward-Looking Statement Disclosure
This news release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond IDdriven’ s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) commercialization of our software programs, (ii) development and protection of our intellectual property, (iii) industry competition, (iv) we may need to raise capital to meet business requirements. More detailed information about IDdriven and the risk factors that may affect the realization of forward looking statements is contained in our filings with the Securities and Exchange Commission which are available on our website and at www.sec.gov. IDdriven assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Company Contact E: [email protected] T: 415.226.7773


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



